Shareholding disclosure

Astellas Pharma Inc

Declared position

3%

Threshold

Fell below threshold

Timeline

Published

09.11.2016

Transaction

03.11.2016

Voting rights breakdown

Voting rights acquired0%
Voting rights sold0%
Below threshold3%

Notice details

CategorySingle shareholder
ExchangeXSWX

Notification ID

TAGB600019

Beneficial owner

Astellas Pharma Inc

Declared address

Astellas Pharma Inc., Tokyo 103-8411

Astellas Venture Capital LLC which is a 99.9% subsidiary of Astellas US Holding, Inc.,1 Astellas Way Northbrook, IL 60062, which is wholly owned subsidiary of Astellas Pharma Inc., Japan. (beneficial owner)

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open